Competitor Analysis: Human Growth Hormone (hGH)

The Competitive Intelligence Report Human Growth Hormone (hGH) as of January 2011 provides a competitor analysis in the development pipeline of biosimilar (biogeneric) versions of somatropin and next generation biobetter/biosuperior hGH products for treatment of growth hormone deficiency (GHD) in childrens and adults and related diseases. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently marketed hGH products and active projects in research and development of novel hGH products. In addition, the report lists company-specific R&D pipelines of hGH products and projects Competitor projects are listed in a tabular format providing Information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Territory,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.